BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 4, 2004
View Archived Issues
Targeting macrophage NF-kappaB activity may improve arthritis in vivo
Read More
Risedronate found effective in osteoporotic women treated with gastric acid inhibitors
Read More
Lipid profile changes found with exemestane in breast cancer patients
Read More
Novel 5-HT6 receptor ligands designed by GSK scientists
Read More
Two series of MCH receptor antagonists developed at Neurocrine
Read More
Millennium presents new ALK5 inhibitors and their potential applications
Read More
Ono researchers develop novel chemokine CCR5 antagonists
Read More
New ZAP70 and Syk kinase inhibitors claimed by NeoGenesis
Read More
New beta-secretase inhibitors under evaluation at GSK
Read More
KuDOS and Maybridge collaborate to develop new PARP inhibitors
Read More
NeuroSearch scientists prepare and test new KCNQ channel modulators
Read More
Serotonin receptor agonists for treatment of ocular hypertension and glaucoma
Read More
Development of novel topoisomerase inhibitors for solid tumor therapy
Read More
Angelini to launch prulifloxacin in Italy
Read More
Pyrazine nucleosides target hepatitis C virus polymerase
Read More
Fast track status for doripenem for nosocomial pneumonia
Read More
Promising antifungal compound effective in vitro and in vivo
Read More
Kahalalide F enters phase II trials for severe psoriasis
Read More
Novel low molecular weight anti-HIV agents by Merck & Co.
Read More
Start-up of Merck Pharma GmbH
Read More
Nuvelo to gain worldwide rights to alfimeprase
Read More
Approvable letter for Nascobal Nasal Spray
Read More
Pivotal study compares Numax to Synagis for RSV
Read More
Maxim to close Ceplene treatment protocol and withdraw NDA
Read More
Axcan launches URSO Forte
Read More
Reata Discovery licenses novel anticancer compounds
Read More
MD-1100 enters phase I study for IBS
Read More
Treatment phase begins in pivotal TRIUMPH study of eculizumab for PNH
Read More
Sosei launches U.S. company targeting CNS disorders
Read More
Sucampo and Takeda enter collaboration and license agreement for lubiprostone
Read More
Antiinflammatory mechanism of ajulemic acid examined in vitro
Read More
Everolimus improves methotrexate efficacy in RA
Read More